What question did this study set out to answer?

To delineate the context-dependent roles of glutamine metabolism in driving tumor cell proliferation, redox balance, epigenetic reprogramming, and immune evasion in triple-negative breast cancer (TNBC).

August 15, 2026Cell Communication and SignalingOpen Access

Glutamine as a context-dependent regulator controlling metabolism and immunity in triple-negative breast cancer

View Full Paper

Ask AI

Bookmark

Authors

AAAnam AftabRiphah International University MPMarilena PontorieroFederico II University Hospital MCMarina La ChimiaMagna Graecia University

Discussion

Member takes

Implication

Mechanistic review uncovers glutamine dependency in triple-negative breast cancer, highlighting novel metabolic vulnerabilities and targets to overcome immune evasion.

Key Points

To delineate the context-dependent roles of glutamine metabolism in driving tumor cell proliferation, redox balance, epigenetic reprogramming, and immune evasion in triple-negative breast cancer (TNBC).
Reviewed molecular and transcriptional mechanisms regulating glutamine uptake and processing in TNBC subtypes.
Assessed metabolic pathways, including the FOXM1/FUS/SLC7A5 axis and ER-PPP/H6PD pathway, alongside tumor microenvironment dynamics involving T cells and macrophages.
Glutamine metabolism acts as an essential nutrient source and regulatory driver of redox homeostasis and epigenetic remodeling in a definable subset of TNBC.
Tumor glutamine utilization creates spatial immune-metabolic competition, suppressing T cells and modulating macrophages to promote immune evasion and therapy resistance.

Cite This Study

Aftab et al. (2026) studied this question.

synapsesocial.com/papers/6a8019f175c2e31742c86265 https://doi.org/10.1186/s12964-026-03150-1

View Full Paper

Ask AI

Bookmark

August 15, 2026Cell Communication and SignalingOpen Access

Glutamine as a context-dependent regulator controlling metabolism and immunity in triple-negative breast cancer

View Full Paper

Ask AI

Bookmark

Authors

AAAnam AftabRiphah International University MPMarilena PontorieroFederico II University Hospital MCMarina La ChimiaMagna Graecia University

Discussion

Member takes

Implication

Mechanistic review uncovers glutamine dependency in triple-negative breast cancer, highlighting novel metabolic vulnerabilities and targets to overcome immune evasion.

Key Points

To delineate the context-dependent roles of glutamine metabolism in driving tumor cell proliferation, redox balance, epigenetic reprogramming, and immune evasion in triple-negative breast cancer (TNBC).
Reviewed molecular and transcriptional mechanisms regulating glutamine uptake and processing in TNBC subtypes.
Assessed metabolic pathways, including the FOXM1/FUS/SLC7A5 axis and ER-PPP/H6PD pathway, alongside tumor microenvironment dynamics involving T cells and macrophages.
Glutamine metabolism acts as an essential nutrient source and regulatory driver of redox homeostasis and epigenetic remodeling in a definable subset of TNBC.
Tumor glutamine utilization creates spatial immune-metabolic competition, suppressing T cells and modulating macrophages to promote immune evasion and therapy resistance.

Cite This Study

Aftab et al. (2026) studied this question.

synapsesocial.com/papers/6a8019f175c2e31742c86265 https://doi.org/10.1186/s12964-026-03150-1

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark